Human Genome Sciences CEO Is Former TAP President Thomas Watkins
This article was originally published in The Pink Sheet Daily
Executive Summary
Watkins joins HGS after serving as head of TAP Pharmaceuticals for six years. HGS focused its CEO search on candidates with late-stage product development experience; the firm's lead candidate LymphoStat-B is in Phase II for RA and lupus.